Mark Fox Email
Finance Director @ Kesmalea Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark Fox Location
- Great Gransden, GB
Mark Fox Work
- Finance Director @ (February 2024 - Present)
- Finance Director @ Quell Therapeutics Ltd (August 2019 - February 2024)
- Director Of Finance And Administration @ GYROSCOPE Therapeutics Ltd (December 2017 - August 2019)
- Finance Director @ North West London Pathology (hosted by Imperial College Healthcare NHS Trust) (March 2017 - December 2017)
- Finance and Operations Director @ The Pathology Partnership (hosted by Cambridge University Hospitals NHS Foundati (August 2014 - November 2016)
- Group FP and A Director @ (January 2013 - July 2014)
- Global FP and A Director - Chemicals and Pharmaceuticals @ (April 2012 - December 2012)
- EU Finance Director @ (November 2008 - April 2011)
- Finance Director @ Orchid Cellmark Ltd (October 2004 - November 2008)
- Finance Director - Europe, Oncology Division @ (January 2001 - January 2004)
- Finance Director - W. Europe, Oncology Division @ ASTA Medica AG (January 2000 - January 2001)
- Finance Manager - UK @ ASTA Medica AG (January 1998 - January 2000)
- Senior Director - Finance and Admin, Europe @ US Bioscience Inc. (January 1990 - January 1998)
- Divisional Accountant - Fine Chemicals Division @ (January 1988 - January 1990)
- Finance Manager @ Agricultural Technology Ltd (January 1986 - January 1988)
- Project Accountant @ Schweppes Ltd (January 1984 - January 1986)
Mark Fox Education
- University of Hertfordshire
(Bachelor of Arts (B.A.), Business Studies)
1979-1983 - Hills Road Sixth Form College, Cambridge, UK
Mark Fox Skills
- Pharmaceutical Industry
- Business Planning
- Biotechnology
- Change Management
- Mergers & Acquisitions
- International Business
- Sarbanes-Oxley Act
- Financial Reporting
- Financial Analysis
- Internal Controls
- Medical Devices
- Start-ups
- Mergers
- Finance
- Business Analysis
- Start Ups
- Mergers and Acquisitions
- Sarbanes Oxley Act
Mark Fox Summary
- Mark Fox, based in Great Gransden, GB, is currently a Finance Director at Kesmalea Therapeutics. Mark Fox brings experience from previous roles at Quell Therapeutics Ltd, GYROSCOPE Therapeutics Ltd, North West London Pathology (hosted by Imperial College Healthcare NHS Trust) and The Pathology Partnership (hosted by Cambridge University Hospitals NHS Foundati. Mark Fox holds a 1979 - 1983 University of Hertfordshire. With a robust skill set that includes Pharmaceutical Industry, Business Planning, Biotechnology, Change Management, Mergers & Acquisitions and more. Mark Fox has 2 emails on RocketReach.
Looking for a different Mark Fox?
Find contact details for 700 million professionals.
Others Named Mark Fox
Mark Fox
Managing Partner
Darien, CT, US
Mark Fox
Business Consultant
Fetcham, GB
Mark Fox
Founder and CEO
New York, NY, US
Mark Fox
Vice President of Customer Success
Ashland, VA, US
Mark Fox
President
New York, NY, US
Mark Fox
Chairman
Parshall, ND, US
Mark Fox
Chief Executive
London, GB
Mark Fox
President
Pensacola, FL, US
Mark Fox
Incoming President and CEO
Cleveland, OH, US
Top Kesmalea Therapeutics Employees
Justin Bower
Vice President of Discovery and Technology Development
Scotland, United Kingdom
Mark Fox
Finance Director
Great Gransden, GB
Yasmin Charabati
Executive Assistant and Office Manager
United Kingdom
Silvia Lovera
Principal Scientist
Turin, IT
Habib Bouguenina
Principal Scientist
United Kingdom
Robert Johnson
Chief Executive Officer
London, GB
Myrianni Constantinou
Senior Scientist
London, GB
Oliver Hsia
Principal Scientist
London, GB
Valeriya Pankova
Scientist
London, England, United Kingdom
John Wong
Programme and Portfolio Manager
United Kingdom
Lior Soday
Senior Scientist
London, GB
Jack Howden
Senior Scientist - CNS
London, GB
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co